PR Source Quebec City (Quebec, Canada) and Saint Paul (Minnesota, USA), January 16, 2012 – Medicago Inc. (MDG: TSX), a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus Like Particles, and…

The White House Office of the Press Secretary For Immediate Release December 08, 2011 We Can’t Wait: Obama Administration Announces $2 Billion in Resources to Support Job-Creating Startups Today, the White House announced administrative and private sector actions that will…

Taking another step forward after the failure of a late-stage trial of its lead drug last year, MacroGenics has bagged a pharma deal to fuel development of an immune-stimulating antibody against cancer. Servier, France’s second-largest drugmaker, has ponied up $20 million upfront in the deal that gives it an option to develop and commercialize the drug, dubbed MGA271, for the European market.

Source: SignonSanDiego As part of a global restructuring strategy launched early this year, Pfizer said this week that it will consolidate its animal medical test manufacturing operations to its Synbiotics plant in the Rancho Bernardo area of San Diego. The…

Source: BioProcess International France Biotech (the French association of life-science companies) presented the results of its “Life Science Panorama 2010” survey at the BioVision world life-sciences forum in Lyons, France, on 29 March 2011. The survey describes major trends for…